BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33999322)

  • 21. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.
    Scallan C; Strand L; Hayes J; Kadura S; Collins B; Ho L; Spada C; Canestaro W; Kolb M; Raghu G
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34112729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor self-rated oral health associated with poorer general health among Indigenous Australians.
    Ju X; Hedges J; Garvey G; Smith M; Canfell K; Jamieson L
    BMC Public Health; 2021 Mar; 21(1):424. PubMed ID: 33648472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
    Abramson MJ; Murambadoro T; Alif SM; Benke GP; Dharmage SC; Glaspole I; Hopkins P; Hoy RF; Klebe S; Moodley Y; Rawson S; Reynolds PN; Wolfe R; Corte TJ; Walters EH;
    Thorax; 2020 Oct; 75(10):864-869. PubMed ID: 32660982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
    Bae E; Choi SE; Lee H; Shin G; Kang D
    BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.
    Moodley Y; Goh N; Glaspole I; Macansh S; Walters EH; Chapman S; Hopkins P; Reynolds PN; Zappala C; Cooper W; Mahar A; Ellis S; McCormack S; Darbishire W; Wood-Baker R; Corte TJ;
    Respirology; 2014 Oct; 19(7):1088-91. PubMed ID: 25123691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
    Meregaglia M; Whittal A; Nicod E; Drummond M
    Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reference set of Health State Utility Values for gambling problem behaviour, a survey of the Australian general population: implications for future healthcare evaluations.
    Moayeri F
    Expert Rev Pharmacoecon Outcomes Res; 2020 Feb; 20(1):115-124. PubMed ID: 31003582
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden and health state utility values of eating disorders: results from a population-based survey.
    Le LK; Mihalopoulos C; Engel L; Touyz S; González-Chica DA; Stocks N; Hay P
    Psychol Med; 2021 Jan; 51(1):130-137. PubMed ID: 31670627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
    Tsai APY; Hur SA; Wong A; Safavi M; Assayag D; Johannson KA; Morisset J; Fell C; Fisher JH; Manganas H; Shapera S; Cox G; Gershon AS; Hambly N; Khalil N; To T; Wilcox PG; Halayko A; Kolb MR; Ryerson CJ
    Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer.
    Blom EF; Haaf KT; de Koning HJ
    Pharmacoeconomics; 2020 Nov; 38(11):1187-1200. PubMed ID: 32754857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
    Cheng Q; Kularatna S; Lee XJ; Graves N; Pacella RE
    Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
    Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
    Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.